AlphaGen Therapeutics

Develops targeted radioligand therapies (RLTs) to improve cancer treatment globally.
Develops targeted radioligand therapies (RLTs) to improve cancer treatment globally.

Sector

Life Sciences

Category

Therapeutics

Location

Shanghai, China

Initial Investment

2023
AlphaGen Therapeutics

AlphaGen Therapeutics is a radiopharmaceutical company focused on the discovery, development and commercialization of innovative targeted radioligand therapies (RLTs). Leveraging its cutting-edge technology platform, the company aims to develop targeted RLTs for patients in China and around the world.